RegulatoryJul 27, 2026, 07:01 AM
Picard Medical NYSE American Compliance Plan Accepted
AI Summary
Picard Medical, Inc. announced that NYSE American LLC has accepted its plan to regain compliance with the exchange's continued listing standards. This acceptance allows the company to continue listing and trading its common stock on the NYSE American under the ticker symbol 'PMI'. The company has been granted a compliance period through November 8, 2027, during which it will execute operational, strategic, and financial initiatives. Interim CEO Richard Fang expressed pleasure with the decision, highlighting progress in advancing the Emperor Total Artificial Heart platform and strengthening the company's financial position.
Key Highlights
- NYSE American accepted Picard Medical's plan to regain compliance with listing standards.
- Company's common stock will continue to be listed and traded on NYSE American under 'PMI'.
- Picard Medical has been granted a compliance period through November 8, 2027.
- Company is advancing its next-generation Emperor Total Artificial Heart platform.
- Picard Medical is strengthening its financial position and supporting patients with SynCardia Total Artificial Heart.
Price Impact
More from PMI